USAEUROPEViVE
ABOUTSPONSORSHIPFOUNDATION
Logo Hlth
Logo Hlth
02 Nov 2021 | 03:45 PM GMT
Past Meeting

DTx last mile delivery - HCPs and patients adoption

Anchored by:

Shrawan Patel
General Partner
PHARMSTARS VENTURES

Participants:

Shrawan Patel General PartnerPharmStars VenturesInvestor & Accelerators
Investor & Accelerators
Shrawan Patel
General PartnerPharmStars Ventures
Anish Shindore Founder & Managing PartnerGSD HealthHealth Tech & Solutions
Health Tech & Solutions
Anish Shindore
Founder & Managing PartnerGSD Health
Ary Deleray Digital Health Business LeaderRocheLife Sciences, Pharma & Biotech
Life Sciences, Pharma & Biotech
Ary Deleray
Digital Health Business LeaderRoche
Christopher Hall Commercial Director, APACMarula Health
Christopher Hall
Commercial Director, APACMarula Health
Jim Howard CEOReadout HealthOther
Other
Jim Howard
CEOReadout Health
Jin Lee Director of Digital HealthAstellas Pharma, IncOther
Other
Jin Lee
Director of Digital HealthAstellas Pharma, Inc
JM
john mattison CMIOACPHealth System & Providers
JM
Health System & Providers
john mattison
CMIOACP
Kyloon Chuah Co-Founder, Chief Product & Tech OfficerVeriteosOther
Other
Kyloon Chuah
Co-Founder, Chief Product & Tech OfficerVeriteos
Randy Horton VP of Solutions and PartnershipsOrthogonalOther
Other
Randy Horton
VP of Solutions and PartnershipsOrthogonal
Ricardo C. Berrios Co-Founder & CEOAdhera Health, Inc.Startup
Startup
Ricardo C. Berrios
Co-Founder & CEOAdhera Health, Inc.
Vasyl Pyrozhyk Vice PresidentSMBCOther
Other
Vasyl Pyrozhyk
Vice PresidentSMBC

About this Meeting

While the DTx market is growing exponentially, the scale of usage from the physician and patient cohorts remains low.  Despite proven clinical outcomes, regulatory approvals, usage and spread remains slim. For example, even though German DiGA has 20 approved products so far, their prescription and adoption have not taken off yet. Join us in this informal conversation where we will discuss the main challenges around HCP and Patient adoption of DTx; we will talk about: 

  •  How do we make HCPs aware of DTx solutions? Should we use the same model used for drugs, or what are the alternatives? 
  •  DTx integration into physicians’ tools (like EMR, CDSS, etc) and workflow so that they are able to prescribe/recommend a DTx - Challenges and best practices
  •  How do we ensure the proper onboarding for DTx products? Does the physician need to know how to do the patient onboarding? Is it a pharmacist job, is it patients, is it developers? 
  •  Why would physicians want to prescribe/recommend a DTx product? What are their motivations? Is being reimbursed a must so that a physician wants to recommend/prescribe a product?

About Us

HLTH Inc. is a dynamic community delivering unique value to the healthcare industry through a mix of unparalleled global events, inspirational content, and impact-driven initiatives.

Hyve Logo

USA Event Dates

2026 | HLTH: Nov 15 – 18 | Las Vegas | Register | Sponsor
2027 | ViVE: Mar 14 – 17 | Nashville | Be First to Know | Sponsor
2027 | HLTH: Oct 17 – 20 | Las Vegas, NV

Europe Event Dates

2027 | HLTH Europe: Jun 21 – 24 | Amsterdam | Sponsor
2028 | HLTH Europe: Jun 19 – 22 | Amsterdam

Important Notice on Hotel Scams

Any communication that claims to represent HLTH or any third party offering discounted hotel rooms or attendee lists is NOT AFFILIATED with HLTH and should be considered fraudulent. Please book your accommodations only through HLTH’s official channels to ensure authenticity and security.

© 2026 HLTH, INC. by Hyve Group - All Rights Reserved

About usPrivacy Policy Contact us